HUMAN DISEASE MODELED by slc24a5^b1/+ + MO2-dok7b

Human Disease	Conditions	Citations
congenital myasthenic syndrome	standard conditions	McMacken et al., 2018

GENE EXPRESSION
Gene expression in slc24a5^b1/+ + MO2-dok7b

PHENOTYPE
Phenotype in slc24a5^b1/+ + MO2-dok7b

Phenotype	Conditions	Figures
horizontal myoseptum neuromuscular junction morphology, abnormal	standard conditions	Fig. 2  from McMacken et al., 2018
horizontal myoseptum neuromuscular junction morphology, ameliorated	chemical treatment by environment: albuterol	Fig. 2  from McMacken et al., 2018
myotome cholinergic synapse amount, ameliorated	chemical treatment by environment: albuterol	Fig. 2  from McMacken et al., 2018
myotome cholinergic synapse decreased amount, abnormal	standard conditions	Fig. 2  from McMacken et al., 2018
thigmotaxis disrupted, abnormal	standard conditions	Fig. 1 from McMacken et al., 2018
thigmotaxis process quality, ameliorated	chemical treatment by environment: albuterol	Fig. 1 from McMacken et al., 2018
whole organism decreased mobility, abnormal	standard conditions	Fig. 1 from McMacken et al., 2018
whole organism mobility, ameliorated	chemical treatment by environment: albuterol	Fig. 1 from McMacken et al., 2018